期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

局部晚期非小细胞肺癌的综合治疗

Combined modality therapy for local advanced non-small cell lung cancer ZHANG Bin. Department of Radiation
原文传递
导出
摘要 综述近年来局部晚期非小细胞肺癌（NSCLC）放射治疗、化学治疗和放化疗综合治疗方面的临床研究进展。介绍放射治疗包括常规分割放疗、超分割放疗和三维适形放疗等的发展，不同化疗方案的疗效分析及对比，推荐较为合理的单纯化疗和放化疗结合的治疗方案及分子靶向药物治疗的进展。同期放化疗与序贯放化疗在局部控制率和生存率上的比较，显示了综合治疗的优势。 This paper reviews the latest developments in radiotherapy, chemotherapy and chemoradiotherapy for local advanced non-small cell lung cancer in the past years. Radiotherapy, includes conventional fractionated radiotherapy, accelerated hypeff-raction radiotherapy and three-dimensional radiotherapy etc. Chemotherapy, includes the analysis of effects of various chemotherapeutic regimens, recommending the reasona- ble methods of chemotherapy and chemoradiotherapy and the development of molecular targeted therapy. Sequential chemoradiotherapy and concurrent chemoradiotherapy show advantagement chemoradiotherapy on the local control rate and survival rate.
作者 张彬(综述) 韩春(审校)
机构地区 河北医科大学第四医院放疗科
出处 《国际肿瘤学杂志》 CAS 2008年第3期198-201,共4页 Journal of International Oncology
关键词 癌 非小细胞肺 放射疗法 药物疗法 综合疗法 Carcinoma, non-small-cell lung Radiotherapy Drug therapy Combined modality therapy
分类号 R730.53 [医药卫生—肿瘤]
  • 相关文献

参考文献13

  • 1Saunders MI, Dische S, Barrett A,et al. Randomised multieentre trials of CHART vs conventional radiotherapy in head and neck and non- small-cell lung cancer: an interim report. CHART Steering Committee. Br J Cancer, 1996, 73(12) :1455-1462.
  • 2Morris DE, Rosenman JG, Halle JS, et al. Induction chemotherapy followed by dose- escalated thoracic 3- dimensional conformal radiation therapy to 90GY with concurrent chemotherapy in stage Ⅲ A/B non- small ceB lung cancer; a phase Ⅰ radiation dose escalation trial. Int J Radiat Oncol Boil Phys, 2003, 57 (2) : 138-139.
  • 3吴开良,蒋国梁,廖源,钱浩,王丽娟,赵森.非小细胞肺癌三维适形放射治疗临床Ⅰ和Ⅱ期剂量递增试验结果分析[J].中华放射肿瘤学杂志,2003,12(1):10-13. 被引量：113
  • 4Hotta K, Matsuo K, Ueoka H et al. Meta-analysis of randomized clinical trials comparing patients with advanced non-small-cell lung cancer. J Clin Oncol, 2004, 22(19) :3852-3859.
  • 5Ardizzoni A, Boni L, Tiseo M, et al. CISCA (CISplatin versus CArboplatin) Meta-analysis Group. Cisplatin- versus carboplatin- based chemotherapy in first-line treatment of advanced non-small-cell lung cancer: an individual patient data meta-analysis. J Natl Cancer Inst, 2007, 99( 11 ) :847-857.
  • 6Belani CP. Optimizing chemotherapy for advanced non-small cell lung cancer: focus on docetaxel. Lung Cancer, 2005, 50( Suppl 2):S3-8.
  • 7胡兴胜,张湘茹.长春瑞滨与紫杉醇联合铂类治疗老年晚期非小细胞肺癌临床对照研究[J].中国肿瘤临床与康复,2005,12(5):409-412. 被引量：2
  • 8Yoh K, Kubota K, Kakinuma R, et al. Phase Ⅱ trial of carboplatin and paclitaxel in non-small cell lung cancer patients previously treated with chemotherapy. Lung Cancer, 2007, 58( 1 ) :73-79.
  • 9Komaki R, Scott CB, Sanse WT, et al. Induction cisplatin/vinblastine and irradiation vs. irradiation in unresectable squamous cell lung cancer: failure patterns by cell type in RTOG 88-08/ECOG 4588.Radiation Therapy Oncology Group. Eastern Cooperative Oncology Group. Int J Radiat Oncol Biol Phys, 1997, 39 (3) :537-544.
  • 10Huncharek M, McGarry R. A meta-analysis of the timing of chest irradiation in the combined medality treatment of limited-stage small cell lung cancer. Oncologist. 2004, 9(6 ) :665-672.

二级参考文献26

  • 1Comella P, Frasci G, Panza N,et al. Randomized trial comparing cisplatin, gemcitabine,and vinorelbine with either cisplatin and gemcitabine or cisplatin and vinorelbine in advanced non-small-cell lung cancer: interim analysis of a phase Ⅲ trial of the Southern Italy Cooperative Oncology Group[J]. J Clin Oncol, 2000, 18(7): 1451-1457.
  • 2Hennessy BT, Hanrahan EO, Breathnach OS. Chemotherapy optionsfor the elderly patient with advanced non-small cell lung cancer[J].Oncologist,2003,8(3): 270-277.
  • 3Gebbia V, Galetta D, Riccardi F, et al. Vinorelbine plus cisplatin versus cisplatin plus vindesine and mitomycin C in stage ⅢB-Ⅳ non-small cell lung carcinoma: a prospective randomized study[J].Lung Cancer,2002,37(2):179-187.
  • 4Hennessy BT, Hanrahan EO, Breathnach OS. Chemotherapy options for the elderly patient with advanced non-small cell lung cancer[J].Oncologist, 2003, 8(3): 270-277.
  • 5Kelly K, Crowley J, Bunn PA, et al. Randomized phase Ⅲ trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non-small-cell lung cancer: a Southwest Oncology Group Trial[J].J Clin Oncol,2001,19(13):3210-3218.
  • 6Rodriguez J, Pawel J, Pluzanska A, et al. A multicenter, randomized phase Ⅲstudy of docetaxel + cisplatin (DC) and docetaxel + carboplatin (DCB) vs vinorebline+cisplatin (VC) in chemotherapy na? Of patients with advanced and metastatic non-small cell lung cancer[J].Proc Am Soc Clin Oncol, 2001,32:1252.
  • 7Abratt RP,Szczesna A,Mattson K, et al.Vinorelbine (NVB)-carboplatin (CBDCA) vs non-platinum doublets in inoperable non-small cell lung cancer(NSCLC) patients(pts)-final results of the Glob 2 phase Ⅲ with patient benefit analysis[J].Proc Am Soc Clin Oncol, 2004,35:7016.
  • 8Cremonesi M, Mandala M, Cazzanjga M, et al. Vinorelbine and carboplatin in inoperable non-small cell lung cancer: a monoinstitutional phaseⅡstudy[J].Oncology,2003,64(2): 97-101.
  • 9Schiller JH,Harrington D, Belani CP,et al.Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer[J].N Engl J Med,2002,346(2):92-98.
  • 10Langer CJ, Vangel M, Schiller J, et al. Age-specific subanalysis of ECOG 1594: fit elderly patients (70-80 yrs) with NSCLC do as well as younger pts (<70)[J].Proc Am Soc Clin Oncol, 2003,34:2571.

共引文献125

国际肿瘤学杂志
2008年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部